Bioequivalence clinical trial of two formulations of linagliptin

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506562-31-00

Acronym

N-LIA-23-282

Enrollment

Registered

2024-06-13

Start date

2024-06-14

Completion date

2024-08-12

Last updated

2024-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026